-
-
-
-
-
-
-
Theralase(R) Closes $CAN 2.66 Million Financing
-
-
-
-
-
-
-
Theralase(R) Announces Brokered LIFE Financing to Further Advance its Phase II Non-Muscle Invasive Bladder Cancer Clinical Study
-
-
-
-
-
-
-
Theralase(R) Closes Non-Brokered Private Placement and Issues Stock Options
-
-
-
-
-
-
-
Theralase(R) Closes $CAN 1.17 Million Non-Brokered Private Placement
-
-
-
-
-
-
-
Theralase Releases Q322 Interim Financial Statements
-
-
-
1,186,417 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

